Guanidinoacetate-creatine in MS
New paper in J Int Med Res
New paper from ABL has been just published! We evaluated here the effects of GAA-creatine adjuvant intervention in a patient with acute secondary progressive multiple sclerosis. She had made clinical progress at follow-up, with the intensity of fatigue dropping from severe to mild. Magnetic resonance spectroscopy revealed increased brain choline, creatine, N-acetylaspartate, and glutathione. Patients with SPMS may benefit from guanidinoacetate-creatine treatment in terms of patient- and clinician-reported outcomes; this requires additional study. read full paper here.